vs

Side-by-side financial comparison of Northfield Bancorp, Inc. (NFBK) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is the larger business by last-quarter revenue ($44.6M vs $41.3M, roughly 1.1× Northfield Bancorp, Inc.). PACIFIC BIOSCIENCES OF CALIFORNIA, INC. runs the higher net margin — -90.4% vs -1545.5%, a 1455.1% gap on every dollar of revenue. On growth, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. posted the faster year-over-year revenue change (13.8% vs 12.7%). Northfield Bancorp, Inc. produced more free cash flow last quarter ($52.5M vs $-19.9M). Over the past eight quarters, Northfield Bancorp, Inc.'s revenue compounded faster (15.0% CAGR vs 7.3%).

Northfield Bancorp, Inc. is a regional bank holding company based in the United States, operating primarily across the U.S. Northeast region. It provides a full range of personal and commercial banking services including deposit accounts, mortgage loans, commercial lending, and wealth management solutions for retail consumers, small to medium-sized businesses and local community clients.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

NFBK vs PACB — Head-to-Head

Bigger by revenue
PACB
PACB
1.1× larger
PACB
$44.6M
$41.3M
NFBK
Growing faster (revenue YoY)
PACB
PACB
+1.1% gap
PACB
13.8%
12.7%
NFBK
Higher net margin
PACB
PACB
1455.1% more per $
PACB
-90.4%
-1545.5%
NFBK
More free cash flow
NFBK
NFBK
$72.5M more FCF
NFBK
$52.5M
$-19.9M
PACB
Faster 2-yr revenue CAGR
NFBK
NFBK
Annualised
NFBK
15.0%
7.3%
PACB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NFBK
NFBK
PACB
PACB
Revenue
$41.3M
$44.6M
Net Profit
$-27.4M
$-40.4M
Gross Margin
37.1%
Operating Margin
-1263.3%
-92.3%
Net Margin
-1545.5%
-90.4%
Revenue YoY
12.7%
13.8%
Net Profit YoY
-343.6%
-1802.7%
EPS (diluted)
$-0.68
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NFBK
NFBK
PACB
PACB
Q4 25
$41.3M
$44.6M
Q3 25
$39.2M
$38.4M
Q2 25
$38.9M
$39.8M
Q1 25
$34.8M
$37.2M
Q4 24
$36.7M
$39.2M
Q3 24
$31.8M
$40.0M
Q2 24
$31.5M
$36.0M
Q1 24
$31.3M
$38.8M
Net Profit
NFBK
NFBK
PACB
PACB
Q4 25
$-27.4M
$-40.4M
Q3 25
$10.8M
$-38.0M
Q2 25
$9.6M
$-41.9M
Q1 25
$7.9M
$-426.1M
Q4 24
$11.3M
$2.4M
Q3 24
$6.5M
$-60.7M
Q2 24
$6.0M
$-173.3M
Q1 24
$6.2M
$-78.2M
Gross Margin
NFBK
NFBK
PACB
PACB
Q4 25
37.1%
Q3 25
41.4%
Q2 25
36.9%
Q1 25
-3.7%
Q4 24
25.6%
Q3 24
25.0%
Q2 24
16.5%
Q1 24
29.1%
Operating Margin
NFBK
NFBK
PACB
PACB
Q4 25
-1263.3%
-92.3%
Q3 25
37.7%
-101.1%
Q2 25
35.6%
-112.8%
Q1 25
31.0%
-1154.5%
Q4 24
38.0%
-390.1%
Q3 24
27.9%
-160.3%
Q2 24
29.1%
-488.3%
Q1 24
27.2%
-209.6%
Net Margin
NFBK
NFBK
PACB
PACB
Q4 25
-1545.5%
-90.4%
Q3 25
27.4%
-98.9%
Q2 25
24.6%
-105.4%
Q1 25
22.6%
-1146.8%
Q4 24
30.7%
6.0%
Q3 24
20.5%
-151.9%
Q2 24
18.9%
-481.3%
Q1 24
19.9%
-201.4%
EPS (diluted)
NFBK
NFBK
PACB
PACB
Q4 25
$-0.68
$-0.11
Q3 25
$0.27
$-0.13
Q2 25
$0.24
$-0.14
Q1 25
$0.19
$-1.44
Q4 24
$0.27
$-0.44
Q3 24
$0.16
$-0.22
Q2 24
$0.14
$-0.64
Q1 24
$0.15
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NFBK
NFBK
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$164.0M
$279.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$690.1M
$5.3M
Total Assets
$5.8B
$784.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NFBK
NFBK
PACB
PACB
Q4 25
$164.0M
$279.5M
Q3 25
$131.7M
$298.7M
Q2 25
$97.6M
$314.7M
Q1 25
$101.7M
$343.1M
Q4 24
$167.7M
$389.9M
Q3 24
$232.9M
$471.1M
Q2 24
$153.5M
$509.8M
Q1 24
$238.8M
$561.9M
Total Debt
NFBK
NFBK
PACB
PACB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$666.4M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
NFBK
NFBK
PACB
PACB
Q4 25
$690.1M
$5.3M
Q3 25
$719.6M
$36.1M
Q2 25
$710.3M
$61.5M
Q1 25
$711.1M
$91.6M
Q4 24
$704.7M
$506.6M
Q3 24
$699.6M
$453.1M
Q2 24
$693.0M
$492.7M
Q1 24
$698.4M
$649.0M
Total Assets
NFBK
NFBK
PACB
PACB
Q4 25
$5.8B
$784.1M
Q3 25
$5.7B
$803.2M
Q2 25
$5.7B
$825.5M
Q1 25
$5.7B
$860.8M
Q4 24
$5.7B
$1.3B
Q3 24
$5.7B
$1.5B
Q2 24
$5.7B
$1.5B
Q1 24
$5.9B
$1.7B
Debt / Equity
NFBK
NFBK
PACB
PACB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.95×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NFBK
NFBK
PACB
PACB
Operating Cash FlowLast quarter
$53.7M
$-19.1M
Free Cash FlowOCF − Capex
$52.5M
$-19.9M
FCF MarginFCF / Revenue
127.1%
-44.6%
Capex IntensityCapex / Revenue
2.8%
1.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$89.2M
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NFBK
NFBK
PACB
PACB
Q4 25
$53.7M
$-19.1M
Q3 25
$13.9M
$-18.7M
Q2 25
$14.1M
$-29.4M
Q1 25
$9.4M
$-44.1M
Q4 24
$31.1M
$-30.6M
Q3 24
$14.0M
$-45.5M
Q2 24
$6.9M
$-54.3M
Q1 24
$4.2M
$-75.7M
Free Cash Flow
NFBK
NFBK
PACB
PACB
Q4 25
$52.5M
$-19.9M
Q3 25
$13.6M
$-18.8M
Q2 25
$13.9M
$-29.9M
Q1 25
$9.2M
$-45.4M
Q4 24
$30.0M
$-32.3M
Q3 24
$13.7M
$-46.3M
Q2 24
$6.7M
$-55.7M
Q1 24
$3.8M
$-79.6M
FCF Margin
NFBK
NFBK
PACB
PACB
Q4 25
127.1%
-44.6%
Q3 25
34.6%
-48.9%
Q2 25
35.7%
-75.3%
Q1 25
26.3%
-122.3%
Q4 24
81.6%
-82.3%
Q3 24
43.2%
-115.7%
Q2 24
21.1%
-154.8%
Q1 24
12.1%
-205.0%
Capex Intensity
NFBK
NFBK
PACB
PACB
Q4 25
2.8%
1.9%
Q3 25
0.8%
0.2%
Q2 25
0.6%
1.4%
Q1 25
0.7%
3.7%
Q4 24
3.1%
4.1%
Q3 24
0.7%
2.0%
Q2 24
0.8%
4.1%
Q1 24
1.4%
10.0%
Cash Conversion
NFBK
NFBK
PACB
PACB
Q4 25
Q3 25
1.29×
Q2 25
1.48×
Q1 25
1.20×
Q4 24
2.76×
-12.93×
Q3 24
2.14×
Q2 24
1.16×
Q1 24
0.68×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NFBK
NFBK

Segment breakdown not available.

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons